SNX17 (E8F8Y) Rabbit mAb #75885
- WB
Supporting Data
| REACTIVITY | H M R Mk |
| SENSITIVITY | Endogenous |
| MW (kDa) | 55 |
| Source/Isotype | Rabbit IgG |
Application Key:
- WB-Western Blotting
Species Cross-Reactivity Key:
- H-Human
- M-Mouse
- R-Rat
- Mk-Monkey
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
Storage
Protocol
Specificity / Sensitivity
Species Reactivity:
Source / Purification
Background
Sorting nexin-17, or SNX17, has been shown to preferentially drive trafficking of integrins, receptors, and a variety of other proteins away from degradative pathways (1). In addition to PX domain interactions, SNX17 also binds the NPxY motif on the cytoplasmic tails of lipoprotein receptors via its FERM domain (protein 4.1, ezrin, radixin and moesin). Some of these proteins include the low density lipoprotein receptor-related protein 1 (LRP1) and apolipoprotein E receptor 2 (ApoER2) (3,4). LRP1 is known to bind APP, regulating its processing and causing an increase in Aβ production, a known risk factor for AD. By binding APP in addition to LRP1, SNX17 recycles both proteins to the plasma membrane, maintaining normal cell surface levels of each (3). SNX17 acts similarly with ApoER2, facilitating trafficking and increasing recycling to the plasma membrane. This assists in regulating the binding of ApoER2 and reelin, an interaction that is known to be important for neuronal migration and the formation of brain structures in early development, as well as synaptic function, learning, and memory in the adult brain (4). Through these and other interactions, SNX17 has been shown to have a potential role in a wide variety of neuronal pathways and diseases.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.